Usefulness of DWI in preoperative assessment of deep myometrial invasion in patients with endometrial carcinoma: a systematic review and meta-analysis by unknown
Das et al. Cancer Imaging 2014, 14:32
http://www.cancerimagingjournal.com/content/14/1/32RESEARCH ARTICLE Open AccessUsefulness of DWI in preoperative assessment of
deep myometrial invasion in patients with
endometrial carcinoma: a systematic review and
meta-analysis
Sushant K Das1, Xiang K Niu1, Jing L Wang1, Li C Zeng1, Wen X Wang1, Anup Bhetuwal1 and Han F Yang2*Abstract
Background: The objective of this study was to perform a systematic review and a meta-analysis in order to estimate
the diagnostic accuracy of diffusion weighted imaging (DWI) in the preoperative assessment of deep myometrial
invasion in patients with endometrial carcinoma.
Methods: Studies evaluating DWI for the detection of deep myometrial invasion in patients with endometrial carcinoma
were systematically searched for in the MEDLINE, EMBASE, and Cochrane Library from January 1995 to January 2014.
Methodologic quality was assessed by using the Quality Assessment of Diagnostic Accuracy Studies tool. Bivariate
random-effects meta-analytic methods were used to obtain pooled estimates of sensitivity, specificity, diagnostic odds
ratio (DOR) and receiver operating characteristic (ROC) curves. The study also evaluated the clinical utility of DWI in
preoperative assessment of deep myometrial invasion.
Results: Seven studies enrolling a total of 320 individuals met the study inclusion criteria. The summary area under the
ROC curve was 0.91. There was no evidence of publication bias (P = 0.90, bias coefficient analysis). Sensitivity and
specificity of DWI for detection of deep myometrial invasion across all studies were 0.90 and 0.89, respectively. Positive
and negative likelihood ratios with DWI were 8 and 0.11 respectively. In patients with high pre-test probabilities, DWI
enabled confirmation of deep myometrial invasion; in patients with low pre-test probabilities, DWI enabled exclusion of
deep myometrial invasion. The worst case scenario (pre-test probability, 50%) post-test probabilities were 89% and 10%
for positive and negative DWI results, respectively.
Conclusion: DWI has high sensitivity and specificity for detecting deep myometrial invasion and more importantly can
reliably rule out deep myometrial invasion. Therefore, it would be worthwhile to add a DWI sequence to the standard
MRI protocols in preoperative evaluation of endometrial cancer in order to detect deep myometrial invasion, which
along with other poor prognostic factors like age, tumor grade, and LVSI would be useful in stratifying high risk groups
thereby helping in the tailoring of surgical approach in patient with low risk of endometrial carcinoma.
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Endometrial Cancer is the seventh most common malig-
nant disorder, the most common female gynecologic can-
cer, and the fourth most common cancer in women [1].
Histopathological markers for recurrence and poor out-
comes in endometrial cancer are becoming increasingly
important in treatment planning. The PORTEC-1 trial [2]
established certain factors for recurrence in early stage pa-
tients including age, high grade histology, and depth of
myometrial tumor invasion, which was further validated
by Gynecologic Oncology Group (GOG) study 99 [3] into
a subgroup of patients who were deemed as “high inter-
mediate risk” (HIR) for recurrence and decreased overall
survival based on age, tumor grade, lymph vascular space
invasion (LVSI), and depth of myometrial invasion [4].
The depth of myometrial invasion is defined as superficial
i.e. confined to endometrium or inner half (<50%) of the
myometrium; and deep invasion, i.e., invading the outer
half (≥50%) of the myometrium, in contrast to historical
definition where it was defined as superficial, i.e., outer 1/
3rd (33%), middle 1/3rd (<66%) and inner 1/3rd (≥66%) of
myometrial invasion [4,5]. These variables (age, tumor
grade, LVSI and depth of myometrial invasion) display
strong inter-relationship since G1 and G2 tumors tend to
be less invasive and to have less LVSI, while G3 tumors
are more often deeply invasive, and have a greater fre-
quency of LVSI. It is not clear if there is an independent
prognostic variable [4,6]. In particular, histological tumor
grade and depth of myometrial invasion strongly correlate
with the presence of lymph node metastases and overall
patient survival [7]. The incidence of lymph node metasta-
ses increases from 3% with superficial myometrial invasion
to 46% with deep myometrial invasion [8,9]. Although,
more recently, several studies showed the LVSI as a much
stronger independent prognostic factor for lymph node
metastasis, but this does not imply that outer-third inva-
sion and Grade 3 histology are not important poor prog-
nostic factors. Zhang et al. [6], in their study, found that
patients with age greater than 60 years and positive LVSI
were associated with increased local regional recurrence,
while progesterone receptor (PR) status and the depth of
myometrial invasion had significant impacts on distant
failure. Therefore, preoperative information about the
depth of myometrial invasion is essential in tailoring the
surgical approach for these patients. The myometrial inva-
sion ratio determines the International Federation of
Gynecology and Obstetrics stage and thus has a direct in-
fluence on treatment. Although clinical guidelines of the
National Cancer Center Network from the United States
require a complete dissection of pelvic and para-aortic
nodes regardless of the estimated myometrial invasion
[10], certain European groups advocate a less aggressive
surgical approach, with surgical lymphadenectomy used
only for patients with deep myometrial invasion [1].Furthermore, clinical judgment of absent myometrial in-
volvement is critical for young patients with Grade 1 endo-
metrial adenocarcinoma since fertility-preserving treatment
may be an option [11].
To date, magnetic resonance imaging (MRI) is an ac-
curate imaging technique for preoperative assessment of
endometrial cancer and for evaluating the depth of myo-
metrial invasion [12-14]. A recent meta-analysis demon-
strated that contrast enhanced T1-weighted (T1WI)
MRI was substantially better than ultrasonography, CT,
or noncontrast MRI [15]. Moreover, dynamic contrast
enhanced MRI (DCE-MRI) is considered more accurate
than T2-weighted imaging (T2WI) in tumor detection
and in assessing myometrial invasion due to greater con-
trast and clearer demonstration of the border between
the tumor and myometrium in the early phase [16-18].
However, recent concerns with respect to the develop-
ment of nephrogenic systemic fibrosis in patients with
renal insufficiency, who undergo contrast enhanced MRI
[19], are increasing the need of non-enhanced imaging
modalities that might be useful for preoperatively evalu-
ating endometrial cancer. A few studies reported that
DWI might be useful for detecting the depth of myome-
trial invasion with high diagnostic accuracy [20] as well
as predict tumor grade [21]. The objective of this study
was to assess the overall diagnostic value of DWI in the
preoperative assessment of deep myometrial invasion in
patients with endometrial cancer with a meta-analysis,
which to our knowledge had not previously been studied.
Methods
Published methods were used to identify relevant stud-
ies, assess study eligibility, evaluate the methodologic
quality of the studies [22-24], and summarize the diag-
nostic accuracy findings [22-25].
Search strategy
A comprehensive computer literature search was per-
formed to identify English articles examining the diagnos-
tic accuracy of Diffusion Weighted-Magnetic Resonance
Imaging (DW-MRI alone, DWI combined with T2 or
DWI with fused T2 images) for detection of deep myome-
trial invasion in patient with endometrial cancer. The
MEDLINE, EMBASE databases, and Cochrane Library
were searched from January 1995 to January 2014. For the
electronic search, a search algorithm was used that was
based on a combination of the following keywords: (“Dif-
fusion-weighted magnetic resonance images” OR “Diffu-
sion Magnetic Resonance” OR “DW-MRI” OR “DW
magnetic resonance images”) AND (“endometrial Neo-
plasm OR endometrial carcinoma” OR “myometrial inva-
sion”) AND (sensitivity OR specificity OR false negative
OR false positive OR diagnosis OR detection OR accur-
acy). Other databases such as Cancerlit and Cochrane
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ence lists of included studies and review articles were
manually searched.
Study selection
Two investigators, Xiang Ke Niu and Jing Liang Wang,
who were blinded to the journal, author, institution, and
date of publication, independently checked retrieved arti-
cles. According to a standardized data extraction form, all
the abstracts were read to identify the potentially eligible
articles, and after retrieving the full text of these articles it
was determined whether they were exactly eligible or not.
The inclusion criteria were as follows: (a) Articles were
published in English; (b) DW-MRI (DWI without referring
to T2 images, T2 +DWI and DWI with fused T2 images)
was used to evaluate myometrial invasion in endometrial
cancer patient; (c) Uniform standard of reference: depth of
myometrial invasion assessed with histologic specimen
from the uterus obtained at surgery; (d) Results were
reported in sufficient detail to reconstruct contingency
tables of the raw data (i.e., true-positive, true-negative,
false-positive, and false-negative findings). The authors
of studies not reporting with sufficient data were con-
tacted to request for additional information; (e) Concern-
ing the quality of study design, only articles in which the
number of “yes” answers to the 14 questions in the Quality
Assessment of Diagnostic Accuracy Studies (QUADAS)
tool [26] was more than nine were included.
Data extraction and quality assessment
The same two investigators who performed the database
searches also performed the relevant data extraction inde-
pendently. In order to resolve any disagreement between
the reviewers, a third reviewer, Li Chuan Zeng, assessed
all points of disagreement. The majority opinion then was
used for analysis. Relevant studies were further examined
with the QUADAS criteria again. To perform accuracy
analyses, data was extracted on the characteristics of stud-
ies and patients; measurements performed and results. For
each report, the following data items were extracted: au-
thor; year of publication; sample size; description of study
population (age); study design; patient enrollment; inclu-
sion and exclusion criteria, reasons for exclusions from
the analysis; DW-MRI test methods; number of lesions
and interpretation of the test results (blinded or not).
For each study, 2 × 2 contingency tables were extracted
or reconstructed. If diagnostic accuracy was compared be-
tween different groups of observers, only one contingency
table for the findings by observer with highest experience
was included.
Data synthesis and statistical analyses
The primary outcome in the analyses was the performance
of DWI in the diagnosis of deep myometrial invasion inpatients with endometrial cancer, as quantified in terms of
sensitivity, specificity, diagnostic log odds ratios and likeli-
hood ratios with corresponding 95% confidence intervals.
Meta-analytical model
A bivariate mixed-effects regression model [27,28] was
used to summarize the diagnostic results of this study. This
bivariate approach accounts for potential between-study
heterogeneity and incorporates the possible correlation be-
tween the sensitivity (SEN) and the specificity (SPE) [28].
Summary performance estimates
Summary sensitivity and specificity were calculated by
using a bivariate regression approach and derived corre-
sponding positive likelihood, negative likelihood and diag-
nostic odds ratios as functions of these summary estimates.
The derived estimates of sensitivity, specificity, and re-
spective variances were also used to construct a summary
ROC curve [29,30]. The area under the ROC curve was
used as an alternative global measure of test performance
[31]. The DOR which is a single indicator of test accuracy
that comprises a combination of sensitivity and specificity
information was also calculated [32]. The post-test prob-
ability of deep myometrial invasion (Ppost) was calculated
from likelihood ratios by using the Bayes theorem [33].
Positive and negative likelihood ratios (LRs) characterize
the clinical utility of a test and are used to estimate the
post-test probability of disease. The likelihood ratios were
used to simulate three clinical scenarios by using different
pre-test probabilities of deep myometrial invasion (25%,
indicating low clinical suspicion (grade 1); 75%, indicating
high clinical suspicion (grade 3); and 50%, indicating worst
case scenario (grade 2), and by using the likelihood ratios,
post-test probabilities were calculated and plotted on
Fagan nomograms. Likelihood ratios higher than 10 and
lower than 0.1 indicate that the given test generate strong
evidence to rule in or rule out a diagnosis, respectively.
Forest plots, with statistical assessments performed by
using the ×2 test of homogeneity and the inconsistency
index (I2) was used to assess between study variation
(Heterogeneity) where an inconsistency index of 0% in-
dicates no observed heterogeneity, and values greater
than 50% is considered to indicate substantial heterogen-
eity [34].
In test accuracy studies, one of the primary causes of
heterogeneity is the threshold effect, which arises when
different cut-offs or thresholds are used in different
studies to define a positive (or negative) test result. The
Spearman correlation coefficient between the logit of
sensitivity and the logit of (1-specificity) was computed
to assess the threshold effect. A strong positive correl-
ation would suggest a threshold effect, P <0.05 [35,36].
Also the SROC curve illustrates the relationship between
SEN and SPE, determining the presence of a threshold
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ROC space is thought to suggest threshold effect [36,37].
A perfect test has a summary ROC curve with an area
close to 1.0 whereas poor tests have an area under the
ROC curve close to 0.5.
Publication bias was assessed visually by using a scatter
plot of the inverse of the square root of the effective sam-
ple size (1/√ESS ) versus the diagnostic log odds ratio,
which would have a symmetric funnel shape when publi-
cation bias was absent. Formal testing for publication bias
was conducted by using a regression of the diagnostic log
odds ratio against 1/√ESS and weighting it according to
the effective sample size, with P <0.10 indicating signifi-
cant asymmetry [38].
The data was analyzed by using the MIDAS (Meta-
analytical Integration of Diagnostic Accuracy Studies)
command in the Stata 12.0 software (Stata Corporation,
College Station, TX, USA) except threshold effect, which
was analyzed by using Metadisc version 1.4 (Ramón y
Cajal Hospital. Madrid, Spain).
Results
Literature search and selection of studies
The detailed procedure of study selection in the meta-
analysis is shown in Figure 1. An electronic search yielded
59 primary studies of which 47 non-pertinent articles were
excluded after reviewing the title and abstract. Then full-
text reports were obtained for 12 publications. Five articles
were excluded after reviewing the full article for the follow-
ing reasons: (a) the aim of the articles was not to reveal the
diagnostic value of DWI for assessment of deep myome-
trial invasion in patient with endometrial cancer [39-42],Potentially eligible studies 
(n=59)
Full manuscript retrieved 











Figure 1 Flow diagram of studies identified in the systematic review.and (b) researchers in the articles did not have enough data
that could be used to construct or calculate true-positive,
false-positive, true-negative and false-negative results [43].
A total of seven studies [5,20,44-48], which fulfilled all of
the inclusion criteria were considered for the analysis.
Study characteristics
The seven evaluated studies involved 320 women diag-
nosed with endometrial cancer. Of those diagnosed, 79 of
them had deep myometrial invasion while 241 had super-
ficial or no invasion on histopathological examination.
The trials were published between 2000 and 2013. Five tri-
als were prospective and enrolled patient consecutively,
while others were retrospective and did not enroll patient
consecutively or the manner of enrollment was not speci-
fied. All of the studies used DWI alone as an index test to
determine deep myometrial invasion. A histopathological
test was used as a reference gold standard test in each
study. Table 1 shows the principal characteristics of the 12
studies included in the meta-analysis.
Assessment of study quality and publication bias
All seven studies included in the meta-analysis fulfilled
nine or more of the 14 criteria in the Quality Assessment
of Diagnostic Accuracy Studies tool for methodologic
quality. The results of this assessment are presented in
Table 2. Results of the funnel plot asymmetry test for pub-
lication bias analyzed by means of linear regression of the
log odds ratio on effective sample size were not significant
(bias coefficient, 1.69; P = 0.90), and the slope was not sig-
nificant, which suggested no major publication bias
(Figure 2).udies excluded on the basis of abstract 
d language other than English (n=47)
 studies:
ic accuracy of DWI for deep myometrial 
was not assessed rather ADC value was 
(n=4)
nt data to create 2 2 table (n=1)
Table 1 Description of studies included in meta-analysis












Shen 2008 AJR Pro 21 33 - 82
years
DWI + T2 1.5T 1,000 NR
Takeuchi 2009 Acta Radiol Retro 33 24 - 85
years





Lin 2009 Radiology Pro 48 25-80
years
DWI with Fused T2 3.0T 0 and
1000
1 - 21 days
Rechichi 2010 Eur Radiol Pro 47 36 - 84
years
Only DWI (no referring to T2) 1.5T 0 and
500
5-35 days
Beddy 2012 Radiology Retro 48 NR DWI + T2 1.5T 0 and
800
NR
Seo J Magn Reson
Imaging
Pro 52 29 - 75
years
DWIBS with fused T2 3.0T 1000 1 - 20 days
Hori 2013 Eur Radiol Pro 71 31 - 82
years







The study identification (ID) numbers correspond to study numbers on the graphs in Figures 5.
Time interval is the time between DWI examination and surgical procedure to histopathologically confirm the extent of myometrial invasion.
All studies had a standard reference of histopathology i.e., all the patients in each study had pathological confirmation of endometrial cancer by Dilation and
Curettage or endometrial biopsy.
All studies enrolled patients consecutively.
NR = not reported.
*Some patients were evaluated using Magnetic field strength 1.5T while others with 3.0T.
**Pro = Prospective, Retro = Retrospective.
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The sensitivity and specificity of DWI for the diagnosis of
deep myometrial invasion were 0.90 (95% CI: 0.81 - 0.95)
and 0.89 (95% CI: 0.79 - 0.94), respectively (Table 3). Forest
plots of the sensitivity and specificity of DWI in the diag-
nosis of deep myometrial invasion are shown in Figure 3.
The likelihood ratio syntheses gave an overall PLR of 8.08
(4.21 - 15.49) and a NLR of 0.11 (0.06 - 0.22). The diagnos-
tic odds ratio was 71.1 (95% CI: 24.96 - 202.29) (Table 3).Table 2 Criteria found and not found in selected studies acco
studies tool
Criterion Shen et al. Takeuchi et al. Lin e
Patient spectrum Yes Yes Yes
Selection criteria Yes Yes Yes
Reference standard Yes Yes Yes
Time between test Unclear Unclear Yes
Partial verification Yes Yes Yes
Differential verification Yes Yes Yes
Incorporation Yes Yes Yes
Index test, sufficient detail Yes Yes Yes
Reference test, sufficient detail Yes Yes Yes
Test bias Yes Yes Yes
Review bias Unclear Unclear Uncl
Clinical data Unclear Yes Yes
Un-interpretable data Unclear Unclear Uncl
Subject withdrawal Yes Yes Yes
Note: yes = criterion found in given study, No = criterion not found in given study, UEvaluation of clinical utility
The positive and negative likelihood ratios of DWI for the
diagnosis of deep myometrial invasion were 8.07 (95% CI:
4.21 - 15.48) and 0.11 (95% CI: 0.05 - 0.22), respectively.
With a pre-test probability of deep myometrial invasion of
25% (low clinical suspicion), the post-test probability of
deep myometrial invasion, given a negative DWI result,
was 4%, which could be considered sufficient to rule out
deep myometrial invasion (Figure 4a). With a pre-testrding to quality assessment of diagnostic accuracy
t al. Rechichi et al. Beddy et al. Seo et al. Hori et al.
Yes Yes Yes Yes
Yes Yes Yes Yes
Yes Yes Yes Yes
Yes Unclear Yes Yes
Yes Yes Yes Yes
Yes Yes Yes Yes
Yes Yes Yes Yes
Yes Yes Yes Yes
Yes Yes Yes Yes
Yes Yes Yes Yes
ear Unclear Unclear Unclear Unclear
Yes Yes Yes Yes
ear Unclear Unclear Unclear Unclear
Yes Yes Yes Yes












Log Odds Ratio versus 1/sqrt(Effective Sample Size)(Deeks)
Figure 2 Results of Deek’s funnel plot asymmetry test for publication bias. The non-significant slope indicates that no significant bias was
found. ESS = effective sample size.
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ical suspicion), the post-test probability of deep myome-
trial invasion, given a positive DWI result, was 96%. Thus,
a positive DWI result could be considered sufficient to
rule in deep myometrial invasion (Figure 4c). With a pre-
test probability of DWI of 50% (worst-case scenario), the
post-test probability of deep myometrial invasion, given a
positive DWI result, was 89%, and the post-test probability
of deep myometrial invasion, given a negative DWI result,
was 10% (Figure 4b). Thus, DWI is a useful test in this
situation.
Heterogeneity and threshold effect
The inconsistency index for the overall heterogeneity of
the study was 0% (95% CI: 0 – 100). It is noteworthy
that I2 = 0% in our study should not be interpreted as
homogeneous as I2 estimates may be unreliable due to
lack of power and precision, due to the presence of
time-dependent biases, or due to dependence on trial
weights and precision [49]. In this study, there were only
320 events and 7 trials. It is believed that considerableTable 3 Meta-analysis summary statistics
Parameter Estimates
Sensitivity 0.90 [ 0.81 - 0.95]
Specificity 0.89 [ 0.79 - 0.94]
Positive LR 8.08 [ 4.21 - 15.49]
Negative LR 0.11 [ 0.06 - 0.22]
Diagnostic score 4.26 [ 3.21 - 5.31]
DOR 71.1 [ 24.96 - 202.29]
Note: Data are summary estimates for all of the studies with all readers.
Numbers in parentheses are 95% Cls. DOR = diagnostic odds ratio,
LR = likelihood ratio.fluctuations is likely to occur in I2 estimates when a
meta-analysis includes less than roughly 500 events and
less than 15 trials [49]. Moreover, if a meta-analysis is
conducted at a time where all trials yield large promising
treatment effects, the similarity across trials will result in
a relatively small I2 estimate. In this study, all the in-
cluded studies had higher diagnostic accuracy for DWI
except for Rechichi and Shen [20,46]. Also from the
mathematical expression, I2 = τ2/ (σ2 + τ2), it is clear that
relatively large sampling errors across trials will result in
small I2 estimates [49].
A Spearman rank correlation was performed as a further
test for the threshold effect and was determined to be
0.214 (P = 0.645), which indicated that there was an ab-
sence of a notable threshold effect in the accuracy esti-
mates among individual studies. Moreover, the pattern of
the SROC curve was not of a “shoulder-arm” shape and
the area under the ROC curve was close to 1.0 (Figure 5).
A subgroup analyses was not performed in this current
study owing to its relatively small study group.
Discussion
The histologic tumor grade and the depth of myometrial
invasion in patients with endometrial cancer correlate
strongly with the prevalence of lymph node metastasis
and with patient survival [50]. The reported five-year sur-
vival rate in patients with deep myometrial invasion or
with grade 3 endometrial cancer is 58% to 59% compared
with 89% for patients with Grade 1 endometrial cancer
[8,51,52]. If there is a deep (>50%) myometrial infiltration,
pelvic and lumbo-aortic nodal dissection must be added
to hysterectomy and salpingoophorectomy [53]. Although
some studies (ASTEC, Benedetti-Panici) [54,55] showed
no therapeutic benefit of combined pelvic and para-aortic
SENSITIVITY (95% CI)
 0.90[0.81 - 0.95]
1.00 [0.40 - 1.00]
0.92 [0.64 - 1.00]
0.86 [0.42 - 1.00]
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0.88 [0.64 - 0.99]
0.83 [0.36 - 1.00]
0.95 [0.74 - 1.00]
STUDY(YEAR)
COMBINED
Q =  2.32, df = 6.00, p =  0.89











 0.89[0.79 - 0.94]
0.82 [0.57 - 0.96]
0.95 [0.75 - 1.00]
1.00 [0.91 - 1.00]
0.71 [0.53 - 0.85]
0.84 [0.66 - 0.95]
0.91 [0.79 - 0.98]
0.85 [0.72 - 0.93]
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Figure 3 Forest plots of studies involving evaluation of the sensitivity and specificity of DWI in the diagnosis of deep myometrial
invasion in patient with endometrial cancer. Summary sensitivity (a) and specificity (b) of DWI for the diagnosis of deep myometrial invasion








































































































Prior Prob (%) =    50
LR_Positive =     8
Post_Prob_Pos (%) =   89
LR_Negative =  0.11









































































































Prior Prob (%) =    75
LR_Positive =     8
Post_Prob_Pos (%) =   96
LR_Negative =  0.11









































































































Prior Prob (%) =    25
LR_Positive =     8
Post_Prob_Pos (%) =   73
LR_Negative =  0.11
Post_Prob_Neg (%) =     4
Fagan's Nomogram
a b c
Figure 4 Pretest probabilities (Prob) and likelihood ratios (LR). (a) With a pretest probability of deep myometrial invasion of 25% (low
clinical suspicion), the posttest probability of deep myometrial invasion, given a negative DWI result (Post-Neg Probability), is 4%, which can be
considered sufficient to rule out deep myometrial invasion. (b) With a pretest probability of deep myometrial invasion of 50% (worst-case
scenario), the posttest probabilities of deep myometrial invasion, given positive and negative DWI results, are 89% and 10%, respectively. Thus, it
is a useful test in this situation. (c) With a pretest probability of deep myometrial invasion of 75% (high clinical suspicion), the posttest probability
of deep myometrial invasion, given a positive DWI result (Post-Pos Probability), is 96%; thus, a positive DWI result can be considered sufficient to
rule in deep myometrial invasion.
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Figure 5 Summary ROC (SROC) curve for the six included
studies. Numbers in brackets are 95% CIs. AUC = area under ROC
curve, SENS = sensitivity, SPEC = specificity.
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these studies had some limitations. While in the ASTEC
study, the follow-up period was short, lymphadenectomy
was selective rather than systematic (nine or fewer lymph
nodes were removed in 35% of patients in the lymphade-
nectomy group), neither of the studies included para-
aortic lymphadenectomy [56,57], which is an important
site of endometrial carcinoma metastases as confirmed by
sentinel lymph node investigation [58], and subsequent ra-
diation was not tailored to the nodal status. Hence, it is
difficult to draw any definite conclusion from these stud-
ies. Furthermore, findings from the SEPAL study [59] sug-
gested that the survival effect of lymphadenectomy was
restricted in low risk patients, but in patients with inter-
mediate or high risk, a complete systematic lymphadenec-
tomy in pelvic and para-aortic regions had substantial
therapeutic effects. The authors recognize that, MR find-
ings are an important predictor of lymph node metastases,
which in combination with tumor grade and histologic as-
sessment could be useful in identifying patients at low risk
for recurrence. This being said, it could also not be denied
that diagnostic imaging and tumor markers have not yet
proved to be accurate enough in the evaluation of tumor
extent to replace surgical staging although it may enable
an optimization of the surgical procedure and result in a
better tailored therapeutic strategy.
The diagnostic accuracy of MRI, CT, and US in asses-
sing myometrial invasion has been extensively evaluated.
Results of a recent meta-analysis [15] showed that, in the
preoperative assessment of myometrial invasion, contrast
material enhanced MRI in the pelvis was substantially bet-
ter than US, CT, and nonenhanced MRI. However, itsinvasiveness and contraindication in patients with renal
insufficiency increases the need of non-invasive test to
evaluate myometrial invasion. DW-MRI offers potential
advantages over DCE-MRI because it does not involve
intravenous administration of a contrast agent and entails
a shorter imaging time.
DWI is a recent prevailing technique that enables dis-
tinction between cancerous and normal tissues, deter-
mines lesion aggressiveness, and monitors responses to
therapy by providing information on extracellular-space
tortuosity and tissue cellularity [60]. The use of a high b
value makes images more sensitive to water diffusion;
hence, it increases contrast enhancement between normal
and cancerous tissues, but with a drawback of decreased
signal intensity and anatomic detail of the adjacent struc-
tures [61]. Thus referring to conventional T2 weighted
image for an anatomical landmark is warranted. More re-
cently, to overcome this morphologic deterioration on
DWI, fusion of T2-weighted and high-b-value DWI has
been applied for malignant tumor screening at 1.5 T [61]
or 3T with improved signal to noise ratio [62]. Further-
more, Gallego et al. [63] found apparent diffusion coeffi-
cient (ADC) mapping overcomes the drawback of high b
values, which was found to cause other lesion like hyper-
plasia also to appear hyper-intense on DWI. In addition to
these refinements, a new DWI technique DWIBS (diffu-
sion-weighted whole-body imaging with background body
signal suppression) has been introduced which is consid-
ered useful in the organs that require the acquisition of
images with free breathing; especially in the abdomen and
pelvis [64,65]. Moreover, DWI can also provide ADC
values of tissue, which is considered to be influenced by
nuclear-to-cytoplasm ratio (NCR) and cellular density
[66-70]. Several studies have showed ADC measurement
has a potential ability to differentiate between normal and
cancerous tissue in the endometrium [71-73] and also sug-
gested that ADC values of endometrial cancer of higher
grade showed a tendency to decrease as compared with
those of lower grade [73], but the mean ADC in assessing
depth of myometrial invasion was found to be insignificant
[40,41,43]. Although, Inoue et al. and Nakamura et al.
[39,42] suggested that a minimum ADC correlates with
prognostic parameters of endometrial carcinoma more
strongly than a mean ADC. A lower minimum ADC sug-
gests higher histological tumor grade and deep myometrial
invasion although more studies would be required to val-
idate ADC measurement for assessing depth of myome-
trial invasion. However, multiple studies have shown DWI
combined with T2 or with application of fused image to
be effective in assessing deep myometrial invasion. So far
myometrial invasion is usually determined by means of an
intraoperative frozen section histological study. It is
noteworthy to mention here that in the study by Gallego
et al. [63], they found a statistically insignificant difference
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myometrial invasion. In fact, sensitivity and NPV of the
DWI sequence were slightly higher, which improves the
possibilities of correctly identifying patients in early stages
of the disease, in which there is no deep invasion, which is
the main objective of pre- and intra-operative evaluations.
Also, while along with deep myometrial invasion, tumor
size as well as lymph node metastasis (LNM) can be
assessed with MRI, it is limited in its capacity in detecting
LNM, which led some authors to consider its role super-
fluous [74] or simply suggesting it should not be per-
formed [75]. Morphologic imaging techniques for
diagnosing nodal involvement (size of short-axis node
diameter greater than 10 mm), have low sensitivity ranging
from about 20% to 65%, with specificity between 73% and
99% [76]. Nonetheless, in the study of Lin et al. [45], the
criteria of combining lymph node size and relative ADC
value increased the sensitivity from 25% to 83% for MRI
in the detection of LNM in endometrial carcinoma. How-
ever, the objective of the present study was to evaluate the
diagnostic accuracy of DWI in assessing deep myometrial
invasion in patients with endometrial carcinoma.
The meta-analysis results reported herein showed that
DWI has excellent accuracy in the diagnosis of deep
myometrial invasion, with an area under the ROC curve
of 0.91. The pooled PLR of 8 suggest that patients with
deep myometrial invasion have approximately 8 fold
chance of having DWI positive compared to patients
with superficial or no myometrial invasion. On the other
hand, the pooled NLR of 0.1 suggest that if the DWI
was negative, the probability that this patient has deep
myometrial invasion was 0.1%, which is low enough to
rule out deep myometrial invasion.
Limitations
Some limitations should be considered when interpreting
the results. First, the sample sizes of several included stud-
ies were rather small and they may not have had adequate
ability to assess the diagnostic accuracy. Second, not all
the studies used similar MRI protocols in the assessment
of deep myometrial invasion. There were differences in
DWI parameters, namely: magnet field strength (1.5T vs.
3T), type of coil and b-value across the studies, which
could not be compared here, owing to relatively small
number of publication that met the inclusion criteria.
Rechichi et al. [20] used DW-MRI without referring to T2
weighted imaging while several other studies either re-
ferred [5,44,46-48] or solely [45] used fusion images for
the assessment of deep myometrial invasion. It is note-
worthy that fusion images are superior to solo DWI or
even to DWI combined conventional T2 images and thus
the latter two might result in misdiagnosis and cause more
false negative results. Also diffusion weighted imaging
with background suppression (DWIBS) used by Seo et al.[44] is considered to have better resolution as compared
to DWI without background suppression. Furthermore, he
fused DWIBS onto T2 images that might have caused bet-
ter depiction of deep myometrial invasion in his study.
Moreover, not all studies had similar planar reconstruction
images. Hori et al. [48] suggested that overall quality re-
garding the ability to assess tumor extent was better with
3D-TSE imaging than 2D-TSE imaging. Apart from all the
variability between studies, different magnetic fields were
also used within one study done by Takeuchi et al. [47]
where different field strengths might have affected diag-
nostic results as some patients were evaluated with 1.5T
while others with 3.0 T. Finally, this meta-analysis was
limited to published (English) studies that may have ne-
gated some of the gray literature. Thus, more studies are
needed to further investigate the diagnostic accuracy of
DWI in evaluation of deep myometrial invasion.Conclusion
In short, even though lymphadenectomy in early (stage I)
endometrial cancer is still controversial, the effect of
lymphadenectomy in patients with intermediate or high
risk for recurrent disease in several studies have still
shown to improve survival rate. As all the poor prognostic
factors for EC are interrelated, information about each fac-
tor could be equally important to clinician in decision
making. So far intra-operative or post-surgical methods
hold higher accuracy in detecting most of these factors.
Pre-operative evaluation of these factors in early stage es-
pecially in young patients could be useful in tailoring the
surgical approach thereby preserving fertility. This being
said, information on myometrial tumor invasion can only
be obtained pre-operatively by imaging techniques.
Among them, DWI has shown better diagnostic accuracy
in predicting deep myometrial invasion and also has
shown to improve detection of LNM through usage of
ADC mapping. Thus, through the presented study here, it
is concluded that it would be worthwhile to add DWI to
standard MRI protocols if pre-operative evaluation of
prognostic factor is being considered in endometrial can-
cer patients. However, further larger prospective studies
are still needed to establish the value of DWI for detecting
deep myometrial invasion in patients with endometrial
carcinoma.
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